{
  "ticker": "CGF",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959328",
  "id": "02959328",
  "pages": 35,
  "price_sensitive": false,
  "date": "20250617",
  "time": "1727",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06kv0vkm364ldj.pdf",
  "summary": "- **Substantial Shareholder Change**: TAL Dai-ichi Life Australia Pty Ltd (TAL) agreed to acquire **33,234,618 shares** (Sale Shares) in Challenger Limited (CGF) from AP Liberty GP, LLC on 16 June 2025.  \n- **Purchase Price**: **A$7.45 per share**, implying total consideration of ~A$247.6 million (33,234,618 \u00d7 A$7.45).  \n- **Conditions**:  \n  - FCA (UK) approval required for change in control of Challenger\u2019s UK subsidiaries.  \n  - APRA approval needed for TAL\u2019s acquisition of a controlling stake in Challenger\u2019s RSE licensee subsidiaries.  \n- **Completion**: Expected by 4 May 2026 (End Date), subject to regulatory approvals.  \n\n*Note*: No material timetable or capital structure impacts disclosed beyond the share transfer. Regulatory approvals are the key pending items.",
  "usage": {
    "prompt_tokens": 9156,
    "completion_tokens": 201,
    "total_tokens": 9357,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T08:00:55.955069"
}